Details
Category: Volume 11 Issue 10 October 2023
Hits: 302

Title: Application Nanobiotech in Neurodegenerative Diseases

Authors: Tukur Zayyanu, Karnawat Monika

 DOI: https://dx.doi.org/10.18535/jmscr/v11i10.12

Abstract

Background:  An early pathogenic role for mitochondrial dysfunction in affected neurons, which occurs before morphological and functional abnormalities, is being supported by expanding information from studies on neurodegenerative diseases. Age is the primary risk factor for numerous diseases that affect people, the degenerative disorders are characterized by an abnormal protein accumulation, progressive loss of neuron cells, and impaired motor or cognitive abilities. One of the fundamental characteristics of aging is mitochondrial malfunction, especially in organs that need a lot of energy, such the heart, muscles, brain, or liver. Small amounts of ROS are produced by natural cell functions such aerobic respiration and inflammatory response mostly in macrophages and hepatocytes.

Aims: This review's objective is to introduce a fresh, innovative nanobiotechnological approach to medical care and issues related to neurodegenerative diseases.

Method: The pathophysiological foundations of the neurological disorders have a number of characteristics. Similarities include oxidative stress (OS) and inflammatory responses. Unfortunately, treating these disorders is difficult. Searches in the databases PubMed, Web of Science, Scopus, and the Cochrane Library found up relevant research on neurodegenerative diseases. The systematic review, which was based on a literature search.

Result: The resultant oxidative stress and respiratory dysfunction contribute to neuronal toxicity and may make neurons more susceptible to continuous attack by aggregation-prone proteins.

Conclusion: The advancements in science and technology of newly evolved materials at the nanoscale is known as nanotechnology, which is a fast growing discipline. Nanobiotechnology approaches, such as Nano delivery-based methodologies, are currently being researched to solve limitation such as  curcumin's stability bioavailability limitations.

Keywords:   Nanobiotech, Oxidative Stress, Neurodegenerative and Mitochondria.

References

  1. Askarizadeh, A., Barreto, G. E., Henney, N. C., Majeed, M., & Sahebkar, A. (2020, July 30). Neuroprotection by curcumin: A review on brain delivery strategies. International Journal of Pharmaceutics. Elsevier B.V. https://doi.org/10.1016/j.ijpharm.2020.119476
  2. Brain, I., & Delivery, T. (2021). Its Brain Targeted Delivery.
  3. Breijyeh, Z., & Karaman, R. (2020, December 1). Comprehensive Review on Alzheimer’s Disease: Causes and Treatment. Molecules. MDPI. https://doi.org/10.3390/MOLECULES25245789
  4. Cenini, G., Lloret, A., & Cascella, R. (2019). Oxidative Stress in Neurodegenerative Diseases: From a Mitochondrial Point of View. Oxidative medicine and cellular longevity, 2019, 2105607. https://doi.org/10.1155/2019/2105607
  5. Dickson D. W. (2018). Neuropathology of Parkinson disease. Parkinsonism & related disorders, 46 Suppl 1(Suppl 1), S30–S33. https://doi.org/10.1016/j.parkreldis.2017.07.033
  6. Fields, M., Marcuzzi, A., Gonelli, A., Celeghini, C., Maximova, N., & Rimondi, E. (2023). Mitochondria-Targeted Antioxidants, an Innovative Class of Antioxidant Compounds for Neurodegenerative Diseases: Perspectives and Limitations. International journal of molecular sciences, 24(4), 3739. https://doi.org/10.3390/ijms24043739
  7. Jakubczyk, K., Dec, K., Kałduńska, J., Kawczuga, D., Kochman, J., & Janda, K. (2020). Reactive oxygen species - sources, functions, oxidative damage. Polski merkuriusz lekarski: organ Polskiego Towarzystwa Lekarskiego, 48(284), 124–127.
  8. Kouli, A., Torsney, K. M., & Kuan, W. L. (2018). Parkinson’s Disease: Etiology, Neuropathology, and Pathogenesis. In T. B. Stoker (Eds.) et. al., Parkinson’s Disease: Pathogenesis and Clinical Aspects. Codon Publications.
  9. Monzio Compagnoni, G., Di Fonzo, A., Corti, S., Comi, G. P., Bresolin, N., & Masliah, E. (2020). The Role of Mitochondria in Neurodegenerative Diseases: the Lesson from Alzheimer's Disease and Parkinson's Disease. Molecular neurobiology, 57(7), 2959–2980. https://doi.org/10.1007/s12035-020-01926-
  10. Rekatsina, M., Paladini, A., Piroli, A., Zis, P., Pergolizzi, J. V., & Varrassi, G. (2020, January 1). Pathophysiology and Therapeutic Perspectives of Oxidative Stress and Neurodegenerative Diseases: A Narrative Review. Advances in Therapy. Adis. https://doi.org/10.1007/s12325-019-01148-5
  11. Ruszkiewicz, J., & Albrecht, J. (2015). Changes in the mitochondrial antioxidant systems in neurodegenerative diseases and acute brain disorders. Neurochemistry international, 88, 66–72. https://doi.org/10.1016/j.neuint.2014.12.012
  12. Sheppard O, Coleman M. Alzheimer’s Disease: Etiology, Neuropathology and Pathogenesis. In: Huang X, editor. Alzheimer’sDisease: Drug Discovery [Internet]. Brisbane (AU): Exon Publications; 2020 Dec 18. Chapter 1. Available from: https://www.ncbi.nlm.nih.gov/books/NBK566126/ doi:10.36255/exonpublications.alzheimersdisease.2020.ch1
  13. Strang, K. H., Golde, T. E., & Giasson, B. I. (2019). MAPT mutations, tauopathy, and mechanisms of neurodegeneration. Laboratory investigation; a journal of technical methods and pathology, 99(7), 912–928. https://doi.org/10.1038/s41374-019-0197-x
  14. Tauffenberger, A., & Magistretti, P. J. (2021). Reactive Oxygen Species: Beyond Their Reactive Behavior. Neurochemical research, 46(1), 77–87. https://doi.org/10.1007/s11064-020-03208-7
  15. Tukur, Z., & Monika, K. (2021). Nano Curcumin: A Review. (2021) BJMLS, 6(1): ISSN 2545 – 5672; EISSN 2635 – 3792.
  16. Wu, Y., Chen, M., & Jiang, J. (2019). Mitochondrial dysfunction in neurodegenerative diseases and drug targets via apoptotic signaling. Mitochondrion, 49, 35–45. https://doi.org/10.1016/j.mito.2019.07.003
  17. Shinn, L. J., & Lagalwar, S. (2021). Treating Neurodegenerative Disease with Antioxidants: Efficacy of the Bioactive Phenol Resveratrol and Mitochondrial-Targeted MitoQ and SkQ. Antioxidants (Basel, Switzerland), 10(4), 573. https://doi.org/10.3390/antiox10040573
  18. Misrani, A., Tabassum, S., & Yang, L. (2021). Mitochondrial Dysfunction and Oxidative Stress in Alzheimer's Disease. Frontiers in aging neuroscience, 13, 617588. https://doi.org/10.3389/fnagi.2021.617588
  19. Ashok, A., Andrabi, S. S., Mansoor, S., Kuang, Y., Kwon, B. K., & Labhasetwar, V. (2022). Antioxidant Therapy in Oxidative Stress-Induced Neurodegenerative Diseases: Role of Nanoparticle-Based Drug Delivery Systems in Clinical Translation. Antioxidants (Basel, Switzerland), 11(2), 408. https://doi.org/10.3390/antiox11020408

Corresponding Author

Tukur Zayyanu

Career Point University, Alaniya, Kota, Rajasthan, India